TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Short Interest Down 31.3% in December

TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Free Report) was the target of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 437,500 shares, a decline of 31.3% from the November 30th total of 637,200 shares. Currently, 2.0% of the shares of the stock are […]

Related Keywords

,Transcode Therapeutics Inc ,Renaissance Technologies ,Sabby Management ,Nasdaq ,Worth Venture Partners ,Transcode Therapeutics ,Get Free Report ,Code Therapeutics ,Venture Partners ,Transcode Therapeutics Daily ,Nasdaq Rnaz ,Marnaz ,Medical ,Stocks ,Options ,Put ,Call ,